Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

News Conference News AHA 2020

Latest Post-DES Drug Trial Tests Aspirin Monotherapy After 1 Month of DAPT

Shelley Wood

November 15, 2020

News Daily News

FDA Grants Stroke Prevention Indication to Ticagrelor

Shelley Wood

November 06, 2020

News Conference News TCT 2020

Ticagrelor Monotherapy Following 3-Month DAPT Cuts Post-PCI Bleeding After STEMI

Todd Neale

October 14, 2020

News Daily News

Features of Complex CAD Carry Progressive Risk in PCI, Registry Confirms

Caitlin E. Cox

October 08, 2020

News Daily News

‘Aspirin-Free’ Antiplatelet Strategy Feasible After PCI, Pilot Study Suggests

Michael O'Riordan

September 18, 2020

News Daily News

Analysis Supports Short DAPT Followed by P2Y12 Inhibitor Monotherapy After DES PCI

L.A. McKeown

August 10, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for July 2020

Shelley Wood

July 31, 2020

Podcast TCTMD Talking Points

TWILIGHT: Impact of Ticagrelor Alone vs. Ticagrelor Plus Aspirin on Ex-Vivo Blood Thrombogenicity in High-Risk Patients Undergoing PCI

July 01, 2020

News Daily News

Short DAPT Reduces Bleeding With No Increase in MACE: Meta-analysis

Yael L. Maxwell

June 30, 2020

News Daily News

P2Y12 Inhibitor Monotherapy Edges Out Aspirin for Secondary Prevention

Yael L. Maxwell

May 15, 2020

Podcast TCTMD Talking Points

TWILIGHT: Ticagrelor Monotherapy vs Ticagrelor Plus Aspirin in High-Risk Patients Undergoing PCI

April 01, 2020

News Conference News ACC 2020

TICO: Ticagrelor Monotherapy After 3 Months of DAPT Curbs Bleeding in Stented ACS Patients

Todd Neale

March 31, 2020

News Conference News ACC 2020

Safety, Efficacy of Ticagrelor Monotherapy Confirmed in Complex PCI, Diabetes

Yael L. Maxwell

March 30, 2020

News Opinion Editor's Corner

A ‘Virtual’ ACC 2020? TCTMD Has You Covered, However Things Roll Out

Shelley Wood

March 16, 2020

Presentation JIM 2020

Ticagrelor Monotherapy Is the Right Choice!

Presenter: Roxana Mehran

February 12, 2020

News Opinion Editor's Corner

The Biggest News of 2019: TCTMD’s Top 10

Shelley Wood

January 01, 2020

Presentation Controversies and Advances 2019

Optimal DAPT Strategies: Lessons Learned, Global Leaders, TWILIGHT, and More

Presenter: Roxana Mehran

November 15, 2019

Advertisement

Latest Post-DES Drug Trial Tests Aspirin Monotherapy After 1 Month of DAPT

FDA Grants Stroke Prevention Indication to Ticagrelor

Ticagrelor Monotherapy Following 3-Month DAPT Cuts Post-PCI Bleeding After STEMI

Features of Complex CAD Carry Progressive Risk in PCI, Registry Confirms

‘Aspirin-Free’ Antiplatelet Strategy Feasible After PCI, Pilot Study Suggests

Analysis Supports Short DAPT Followed by P2Y12 Inhibitor Monotherapy After DES PCI

TCTMD’s Top 10 Most Popular Stories for July 2020

TWILIGHT: Impact of Ticagrelor Alone vs. Ticagrelor Plus Aspirin on Ex-Vivo Blood Thrombogenicity in High-Risk Patients Undergoing PCI

Short DAPT Reduces Bleeding With No Increase in MACE: Meta-analysis

P2Y12 Inhibitor Monotherapy Edges Out Aspirin for Secondary Prevention

TWILIGHT: Ticagrelor Monotherapy vs Ticagrelor Plus Aspirin in High-Risk Patients Undergoing PCI

TICO: Ticagrelor Monotherapy After 3 Months of DAPT Curbs Bleeding in Stented ACS Patients

Safety, Efficacy of Ticagrelor Monotherapy Confirmed in Complex PCI, Diabetes

A ‘Virtual’ ACC 2020? TCTMD Has You Covered, However Things Roll Out

Ticagrelor Monotherapy Is the Right Choice!

The Biggest News of 2019: TCTMD’s Top 10

Optimal DAPT Strategies: Lessons Learned, Global Leaders, TWILIGHT, and More

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content